Exact Mass: 442.2620144
Exact Mass Matches: 442.2620144
Found 217 metabolites which its exact mass value is equals to given mass value 442.2620144
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea. 2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea.
Muzanzagenin
Muzanzagenin is found in green vegetables. Muzanzagenin is a constituent of the wild asparagus (Asparagus africanus) Constituent of the wild asparagus (Asparagus africanus). Muzanzagenin is found in green vegetables.
Prostaglandin G2 2-glyceryl Ester
Prostaglandin G2 2-glyceryl Ester is also known as 2-Glyceryl-prostaglandin g2. Prostaglandin G2 2-glyceryl Ester is considered to be practically insoluble (in water) and acidic
Cystone A
DG(2:0/5-iso PGF2VI/0:0)
DG(2:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(5-iso PGF2VI/2:0/0:0)
DG(5-iso PGF2VI/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/5-iso PGF2VI)
DG(2:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(5-iso PGF2VI/0:0/2:0)
DG(5-iso PGF2VI/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
9-Hydroxynerolidol-9-O-beta-D-glucopyranoside-2-O-acetate
14-phenoxytetradecanyl 3,5-dihydroxybenzoate|pistiphloro-glucinyl ester
10-(2,3-dihydro-5-hydroxy-7-methyl-1-benzofuran-2-yl)-10-hydroxy-6-methyl-2-(4-methyl-3-pentenyl)-(2E,6E)-undecadienoic acid|thunbergol B
3-hexyl-6-(4-hydroxypentyl)-2H-pyran-2-on-4-O-beta-D-glucopyranoside|whitmanoside A
linalool-beta-D-glucopyranoside-2-O-acetate,6O-isovalerate
linalool-beta-D-glucopyranoside-2O-acetate-6O-<2-methylbutyrate>
(22S,25S)-17alpha,26-dihydroxy-22,25-epoxyfurost-4,6-dien-3-one|diosbulbisin D
22-acetylisocyclocitrinol A|22-O-acetylisocyclocitrinol A
Ala Lys Pro Gln
Ala Lys Gln Pro
Ala Pro Lys Gln
Ala Pro Gln Lys
Ala Gln Lys Pro
Ala Gln Pro Lys
Lys Ala Pro Gln
Lys Ala Gln Pro
Lys Pro Ala Gln
Lys Pro Gln Ala
Lys Gln Ala Pro
Lys Gln Pro Ala
Pro Ala Lys Gln
Pro Ala Gln Lys
Pro Lys Ala Gln
Pro Lys Gln Ala
Pro Gln Ala Lys
Pro Gln Lys Ala
Gln Ala Lys Pro
Gln Ala Pro Lys
Gln Lys Ala Pro
Gln Lys Pro Ala
Gln Pro Ala Lys
Gln Pro Lys Ala
Muzanzagenin
2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
(2S)-3,4,4,4-tetradeuterio-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-3-(trideuteriomethyl)butanoic acid
C24H22D7N5O3 (442.27096864600003)
tert-butyl N-[6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexyl]carbamate
C21H38N4O4S (442.26136280000003)
Dotarizine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
N-(2-aminoethyl)ethane-1,2-diamine,dimethyl-bis(oxiran-2-ylmethyl)azanium,hexanedioic acid,chloride
(2E,6E,10E)-1-(2,5-dihydroxy-3-methylphenyl)-13-(3,3-dimethyloxiran-2-yl)-12-hydroxy-3,7,11-trimethyltrideca-2,6,10-trien-5-one
1-[[(2S,3S)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2R,3R)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2R,3R)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2R,3S)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2S,3S)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2S,3R)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2R,3S)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
1-[[(2S,3R)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C24H34N4O4 (442.25799240000003)
2,3-Dihydroxypropyl (2-hydroxy-3-tetradecoxypropyl) hydrogen phosphate
Prostaglandin G2 2-glyceryl Ester
A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin G2 with the 2-hydroxy group of glycerol.
methyl (1r,2r,3s,6s,7s)-3-[(2e,5s)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-1,7-dihydroxy-6-methylbicyclo[4.3.1]decane-2-carboxylate
17-(hydroxymethyl)-7-(4-hydroxyphenyl)-2,10-dimethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-17-ol
12-[(2e)-4-(2,5-dihydroxy-3-methylphenyl)-2-methylbut-2-en-1-yl]-10-hydroxy-6,6,9,9-tetramethyl-8-oxabicyclo[5.4.1]dodec-1(12)-en-2-one
4-hydroxy-3-{[2-(3-hydroxy-2-methylprop-1-en-1-yl)-5a,9b-dimethyl-7-methylidene-octahydro-1h-naphtho[2,1-b]furan-6-yl]methyl}-5,6-dimethylpyran-2-one
2,4,6,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl propanoate
4,5-dihydroxy-2-[(10-hydroxy-2,6,10-trimethyldodeca-2,6,11-trien-4-yl)oxy]-6-(hydroxymethyl)oxan-3-yl acetate
(2e,6e,13e)-1-(2,5-dihydroxy-3-methylphenyl)-15-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,13-triene-5,12-dione
3-formyl-4-[3-(3-hydroxy-4-methylphenyl)-3-oxopropyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate
(6e,10e,14e)-16-(2,5-dihydroxy-3-methylphenyl)-1,12-dihydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,14-tetraen-4-one
[(2r,4ar,8ar)-2-[(1s,2r,4as,8as)-2-hydroxy-2,5,5,8a-tetramethyl-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-7-methyl-6-oxo-2,4a,5,8a-tetrahydrochromen-4-yl]methyl acetate
(2s,4's,4'ar,4'bs,7's,8'ar,10'ar)-4',7'-dihydroxy-2',4'b,6,7,8',8',10'a-heptamethyl-4',4'a,5',6',7',8'a,9',10'-octahydro-3h-spiro[furo[3,2-c]pyran-2,1'-phenanthren]-4-one
(7s,10r)-10-hydroxy-12-{[(2s)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]methyl}-6,6,9,9-tetramethyl-8-oxabicyclo[5.4.1]dodec-1(12)-en-2-one
(3s,4e)-2-hydroxy-2-[(2r,5s,6s,9r,13s,15s)-15-hydroxy-5-methyl-12-oxotetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-6-yl]hex-4-en-3-yl acetate
3-{[(3r,3ar,5ar,6r,7r,9as,9br)-3-carboxy-3,3a,6,7,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalen-6-yl]methyl}-4-hydroxybenzoic acid
(4e)-6-(2,5-dihydroxy-3-methylphenyl)-1-{2-[(2z)-4-hydroxy-4-methylpent-2-enoyl]-1,2-dimethylcyclopentyl}-4-methylhex-4-en-2-one
(1s,3z,3as,4s,6r,7ar)-3-ethylidene-4-isopropyl-7-methylidene-6-{[(2e)-3-methylpent-2-enoyl]oxy}-2-oxo-hexahydroinden-1-yl (2e)-3-methylpent-2-enoate
(4z)-6-(2,5-dihydroxy-3-methylphenyl)-1-[(1s,2s)-2-[(2e)-4-hydroxy-4-methylpent-2-enoyl]-1,2-dimethylcyclopentyl]-4-methylhex-4-en-2-one
3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate
6-(2,5-dihydroxy-3-methylphenyl)-1-{2-[2-(3,3-dimethyloxiran-2-yl)acetyl]-1,2-dimethylcyclopentyl}-4-methylhex-4-en-2-one
6-(2,5-dihydroxy-3-methylphenyl)-1-[2-(4-hydroxy-4-methylpent-2-enoyl)-1,2-dimethylcyclopentyl]-4-methylhex-4-en-2-one
(4e)-6-(2,5-dihydroxy-3-methylphenyl)-1-[(1r,2r)-2-[(2e)-4-hydroxy-4-methylpent-2-enoyl]-1,2-dimethylcyclopentyl]-4-methylhex-4-en-2-one
methyl (1r,2r,3s,6s,7r)-3-[(2e)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-1,7-dihydroxy-6-methylbicyclo[4.3.1]decane-2-carboxylate
(2s)-2-[(1r,2e,5r,9s,11e,15r)-7-hydroxy-2,9,12-trimethyl-16-methylidene-8-oxo-19-oxatricyclo[13.3.1.0⁵,⁹]nonadeca-2,6,11-trien-6-yl]propyl acetate
3-ethylidene-4-isopropyl-7-methylidene-6-[(3-methylpent-2-enoyl)oxy]-2-oxo-hexahydroinden-1-yl 3-methylpent-2-enoate
(4e)-6-(2,5-dihydroxy-3-methylphenyl)-1-{2-[(2e)-4-hydroxy-4-methylpent-2-enoyl]-1,2-dimethylcyclopentyl}-4-methylhex-4-en-2-one
3-{[(3s,3as,5as,6s,7s,9ar,9bs)-3-carboxy-3,3a,6,7,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalen-6-yl]methyl}-4-hydroxybenzoic acid
{3,4,5-trihydroxy-6-[(10-hydroxy-2,6,10-trimethyldodeca-2,6,11-trien-4-yl)oxy]oxan-2-yl}methyl acetate
methyl 2-[(1r,2r,5r,7s,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoate
(7s,10r)-12-[(2z)-4-(2,5-dihydroxy-3-methylphenyl)-2-methylbut-2-en-1-yl]-10-hydroxy-6,6,9,9-tetramethyl-8-oxabicyclo[5.4.1]dodec-1(12)-en-2-one
[2-(2-hydroxy-2,5,5,8a-tetramethyl-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)-7-methyl-6-oxo-2,4a,5,8a-tetrahydrochromen-4-yl]methyl acetate
methyl 3-[1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-1,7-dihydroxy-6-methylbicyclo[4.3.1]decane-2-carboxylate
2-[(1s,2r,5r,7s,8s,11s,12r)-11-(acetyloxy)-2,7-dihydroxy-8-methoxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid
(2e,6e,11s,13e)-1-(2,5-dihydroxy-3-methylphenyl)-15-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,13-triene-5,12-dione
2-(4-{4'-hydroxy-4a,5',5',7a-tetramethyl-6,7-dihydro-5h-spiro[cyclopenta[c]pyran-1,2'-oxolan]-3-yl}-3-methylbut-2-en-1-yl)-6-methylbenzene-1,4-diol
2-{7-hydroxy-2,9,12-trimethyl-16-methylidene-8-oxo-19-oxatricyclo[13.3.1.0⁵,⁹]nonadeca-2,6,11-trien-6-yl}propyl acetate
methyl 2-[(1r,2r,5r,7r,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoate
(1r,2s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-2,3,4,6,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate
3-{[(3r,3ar,6r,7r,9as)-3-carboxy-3,3a,6,7,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalen-6-yl]methyl}-4-hydroxybenzoic acid
(4e)-6-(2,5-dihydroxy-3-methylphenyl)-1-{2-[2-(3,3-dimethyloxiran-2-yl)acetyl]-1,2-dimethylcyclopentyl}-4-methylhex-4-en-2-one
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(4s,6e,10s)-10-hydroxy-2,6,10-trimethyldodeca-2,6,11-trien-4-yl]oxy}oxan-2-yl]methyl acetate
3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl 2-hydroxypropanoate
(2e,6e,10s,11z)-12-(2,5-dihydroxy-4-methylphenyl)-10-hydroxy-6,10-dimethyl-2-(4-methylpent-3-en-1-yl)dodeca-2,6,11-trienoic acid
(1s,2s,3r,4r,6r,8r,9s,10s,13s,14r,16s)-2,4,6,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl propanoate
(4r,7e)-7-methyl-3-methylidene-10-(5-oxo-2h-furan-3-yl)-1-[(1r,6r)-1,2,6-trimethyl-4-oxocyclohex-2-en-1-yl]dec-7-en-4-yl acetate
(10s)-12-(2,5-dihydroxy-4-methylphenyl)-10-hydroxy-6,10-dimethyl-2-(4-methylpent-3-en-1-yl)dodeca-2,6,11-trienoic acid
12-(2,5-dihydroxy-3-methylphenyl)-2-[(3r)-3-hydroxy-4-methylpent-4-en-1-yl]-6,10-dimethyldodeca-2,6,10-trienoic acid
(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate
(7s,10r)-10-hydroxy-12-{[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]methyl}-6,6,9,9-tetramethyl-8-oxabicyclo[5.4.1]dodec-1(12)-en-2-one
(1r,4s,5s,6r,9s,10s,13r,16s)-6-(acetyloxy)-5-formyl-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-16-yl (2e)-2-methylbut-2-enoate
(2s,2's,8'ar)-4,5,7'-trihydroxy-2',4'b,8',8',10'a-pentamethyl-2',3',4',4'a,5',6',7',8'a,9',10'-decahydro-3h-spiro[1-benzofuran-2,1'-phenanthrene]-7-carbaldehyde
(2r,3s,4s,5s,6s)-4,5-dihydroxy-2-{[(4s,6e,10r)-10-hydroxy-2,6,10-trimethyldodeca-2,6,11-trien-4-yl]oxy}-6-(hydroxymethyl)oxan-3-yl acetate
2-[(2e)-4-[(1r,4's,4ar,7ar)-4'-hydroxy-4a,5',5',7a-tetramethyl-6,7-dihydro-5h-spiro[cyclopenta[c]pyran-1,2'-oxolan]-3-yl]-3-methylbut-2-en-1-yl]-6-methylbenzene-1,4-diol
4,5-dihydroxy-6-methyl-2-({2-[4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate
8'-hydroxy-5-(hydroxymethyl)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-17',19'-dien-16'-one
(1r,2s,3r,4r,6s,8s,9r,10r,14r,16r)-2,3,4,6,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate
(2r,3r,4s,5s,6r)-4,5-dihydroxy-2-{[(4s,6e,10r)-10-hydroxy-2,6,10-trimethyldodeca-2,6,11-trien-4-yl]oxy}-6-(hydroxymethyl)oxan-3-yl acetate
(1s,5as,5br,7as,11as,11br,13s,13as)-1-hydroxy-5b,8,8,11a,13a-pentamethyl-3-oxo-1h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-yl acetate
4',7'-dihydroxy-2',4'b,6,7,8',8',10'a-heptamethyl-4',4'a,5',6',7',8'a,9',10'-octahydro-3h-spiro[furo[3,2-c]pyran-2,1'-phenanthren]-4-one
2-[(2e)-4-[(1r,4'r,4as,7ar)-4'-hydroxy-4a,5',5',7a-tetramethyl-6,7-dihydro-5h-spiro[cyclopenta[c]pyran-1,2'-oxolan]-3-yl]-3-methylbut-2-en-1-yl]-6-methylbenzene-1,4-diol
2-[(1s,2r,5r,7r,8s,11s,12r)-11-(acetyloxy)-2,7-dihydroxy-8-methoxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid
3-heptyl-5-hydroxyphenyl 2-heptyl-4,6-dihydroxybenzoate
(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-methyl-2-({2-[(1r,4s)-4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate
(7r)-12-(2,5-dihydroxy-3-methylphenyl)-7-hydroxy-10-methyl-6-methylidene-2-(4-methylpent-3-en-1-yl)dodeca-2,10-dienoic acid
(2e,7r,10e)-12-(2,5-dihydroxy-3-methylphenyl)-7-hydroxy-10-methyl-6-methylidene-2-(4-methylpent-3-en-1-yl)dodeca-2,10-dienoic acid
(5r)-3-[(1r,3as,5ar,9ar,9br,11as)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-hydroxy-5-(hydroxymethyl)furan-2-one
(2z,6e,10r,11z)-12-(2,5-dihydroxy-4-methylphenyl)-10-hydroxy-6,10-dimethyl-2-(4-methylpent-3-en-1-yl)dodeca-2,6,11-trienoic acid
(4e)-6-(2,5-dihydroxy-3-methylphenyl)-1-[(1r,2r)-2-{2-[(2s)-3,3-dimethyloxiran-2-yl]acetyl}-1,2-dimethylcyclopentyl]-4-methylhex-4-en-2-one
12-[4-(2,5-dihydroxy-3-methylphenyl)-2-methylbut-2-en-1-yl]-10-hydroxy-6,6,9,9-tetramethyl-8-oxabicyclo[5.4.1]dodec-1(12)-en-2-one
(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',16',19'-trione
3-({3-carboxy-3,3a,6,7,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalen-6-yl}methyl)-4-hydroxybenzoic acid
(2s)-2-[(1r,2e,5r,9s,11e,14e,16s)-7-hydroxy-2,9,12,16-tetramethyl-8-oxo-19-oxatricyclo[14.2.1.0⁵,⁹]nonadeca-2,6,11,14-tetraen-6-yl]propyl acetate
2-amino-1-[(13z)-8,11-dihydroxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.2.2.0³,⁷]nonadeca-1(17),8,11,13,15,18-hexaen-6-yl]-3-methylbutan-1-one
C24H34N4O4 (442.25799240000003)